Streetbeat News

Products Services

IPHA

SNY

Innate Pharma announced positive Phase 1/2 safety and preliminary efficacy results for SAR'579/IPH6101, a drug for relapsed/refractory acute myeloid leukemia. The drug, developed by Sanofi, was well tolerated up to doses of 3 mg/kg QW with observed clinical benefits.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 7:23 am

GILD

The European Medicines Agency's CHMP granted a positive opinion for the use of Gilead Sciences' Veklury (remdesivir) in COVID-19 patients with severe renal impairment, including those on dialysis. The European Commission will review the recommendation.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 7:16 am

SYNH

FivepHusion, a clinical-stage biotechnology company, has announced a collaboration with Treehill Partners and Syneos Health (NASDAQ:SYNH) to develop and bring a novel, enhanced chemotherapeutic product to market.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 7:13 am

TSLA

Tesla CEO Elon Musk responded to the company's achievements in artificial intelligence (AI) on Twitter, highlighting its self-driving software, custom chips, and humanoid bot. Tesla recently showcased the progress of its Tesla Bot at the annual shareholder meeting, and its Full Self-Driving (FSD) Beta users have driven 190 million miles collectively.

Portfolio Pulse from Anan Ashraf

May 26, 2023 | 5:06 am

META

Elon Musk praised citizen journalism for breaking media monopolies, highlighting its importance amidst contrasting coverage of Instagram's recent outage and technical issues during Ron DeSantis's Twitter Space event. Musk's Twitter and Meta's Instagram have been pitched against each other for a long time.

Portfolio Pulse from Ananya Gairola

May 26, 2023 | 4:13 am

BTCUSD

Tokens named after US election candidates, such as RON (Ron DeSantis) and RFK (Robert F Kennedy Jr), have surged in popularity on decentralized exchanges, with RON experiencing a 7178% rally in the past 24 hours. DeSantis, a Bitcoin supporter, announced his candidacy for the 2024 US presidential election on Twitter.

Portfolio Pulse from Mehab Qureshi

May 26, 2023 | 4:10 am

JAZZ

A new analysis of two clinical trials reveals that Nabiximols, a cannabis-based oral spray developed by GW Pharmaceuticals (now part of Jazz Pharmaceuticals), significantly relieves spasticity in multiple sclerosis (MS) patients. The therapy, marketed as Sativex, is approved for treating MS-related spasticity in many countries, excluding the United States.

Portfolio Pulse from Nicolás Jose Rodriguez

May 26, 2023 | 3:15 am

JAZZ

The ARISTOCRAT study, a world-first clinical trial using cannabis-based drug Sativex to treat aggressive brain tumors, has recruited its first patients. Developed by GW Pharmaceuticals, now part of Jazz Pharmaceuticals (NASDAQ:JAZZ), Sativex was approved by the NHS in 2019 to treat muscle spasms related to multiple sclerosis. The trial aims to determine if Sativex combined with chemotherapy can help kill glioblastoma tumor cells and extend patients' lives.

Portfolio Pulse from Nina Zdinjak

May 26, 2023 | 1:48 am

SONY

Sony Interactive Entertainment unveiled a new game streaming device, Project Q, and gaming earbuds at the PlayStation Showcase. Project Q has an 8-inch display and is designed for streaming games from a PS5 to a handheld screen. The gaming earbuds will work with both the PS5 and PC. A rumor suggests the device will be released in November 2023.

Portfolio Pulse from Franca Quarneti

May 25, 2023 | 11:42 pm

BMR

LAES

NIO

PLTR

SQQQ

Benzinga's Stock Whisper Index highlights five stocks that warrant attention, including Palantir Technologies, Beamr Imaging, Sealsq Corp, Nio Inc, and ProShares Ultra Pro Short QQQ ETF. These stocks are impacted by factors such as Ark Invest's large purchase, integration with Nvidia, and Chinese EV peer XPeng's financial results.

Portfolio Pulse from Chris Katje

May 25, 2023 | 11:30 pm